80_FR_23642 80 FR 23561 - National Cancer Institute; Notice of Closed Meetings

80 FR 23561 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 80, Issue 81 (April 28, 2015)

Page Range23561-23562
FR Document2015-09777

Federal Register, Volume 80 Issue 81 (Tuesday, April 28, 2015) 
[Federal Register Volume 80, Number 81 (Tuesday, April 28, 2015)]
[Notices]
[Pages 23561-23562]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-09777]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c) (4) and 552b(c) (6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Quantitative Imaging for Evaluation of Response to Cancer 
Therapies (U01).
    Date: May 13, 2015.
    Time: 10:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 5W032, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review 
Officer, 9609 Medical Center Drive, Room 7W266, Research Technology 
and Contract Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, Bethesda, MD 20892-9750, (240) 276-
6385, lovingeg@mail.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Name of Committee: National Cancer Institute Special Emphasis 
Panel NCI Omnibus R03 & R21 SEP-2.
    Date: June 1-2, 2015.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 
22102.
    Contact Person: Eun Ah Cho, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, NIH, 9609 Medical Center Drive, 7W104, Bethesda, 
MD 20892-9750, 240-276-6342, choe@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction;

[[Page 23562]]

93.393, Cancer Cause and Prevention Research; 93.394, Cancer 
Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 
93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 
93.398, Cancer Research Manpower; 93.399, Cancer Control, National 
Institutes of Health, HHS)


    Dated: April 22, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-09777 Filed 4-27-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 81 / Tuesday, April 28, 2015 / Notices 23561 meeting is limited only by the space topic. Each speaker is allotted at least 7 Dated: April 22, 2015. available. minutes, which if time permits, may be John R. Bucher, The BSC will provide input to the extended to 10 minutes at the discretion Associate Director, National Toxicology NTP on programmatic activities and of the BSC chair. Persons wishing to Program. issues. A preliminary agenda, roster of present oral comments should register [FR Doc. 2015–09775 Filed 4–27–15; 8:45 am] BSC members, background materials, on the BSC meeting Web site by June 9, BILLING CODE 4140–01–P public comments, and any additional 2015, indicate whether they will present information, when available, will be comments in-person or via the posted on the BSC meeting Web site DEPARTMENT OF HEALTH AND teleconference line, and indicate the (http://ntp.niehs.nih.gov/go/165) or may HUMAN SERVICES topic(s) on which they plan to comment. be requested in hardcopy from the Designated Federal Officer for the BSC. The access number for the National Institutes of Health Following the meeting, summary teleconference line will be provided to minutes will be prepared and made registrants by email prior to the meeting. National Cancer Institute; Notice of available on the BSC meeting Web site. On-site registration for oral comments Closed Meetings The public may attend the meeting in will also be available on the meeting Pursuant to section 10(d) of the person or view the webcast. Registration day, although time allowed for Federal Advisory Committee Act, as is required to view the webcast; the URL comments by these registrants may be amended (5 U.S.C. App.), notice is for the webcast will be provided in the limited and will be determined by the hereby given of the following meetings. email confirming registration. number of persons who register at the The meetings will be closed to the Individuals who plan to provide oral meeting. public in accordance with the comments (see below) are encouraged to Persons registering to make oral provisions set forth in sections 552b(c) register online at the BSC meeting Web (4) and 552b(c) (6), Title 5 U.S.C., as comments are asked to send a copy of site (http://ntp.niehs.nih.gov/go/165) by amended. The grant applications and their statement and/or PowerPoint June 9, 2015, to facilitate planning for the discussions could disclose the meeting. Individuals interested in slides to the Designated Federal Officer by June 9, 2015. Written statements can confidential trade secrets or commercial this meeting are encouraged to access property such as patentable material, the Web site to stay abreast of the most supplement and may expand upon the oral presentation. If registering on-site and personal information concerning current information regarding the individuals associated with the grant meeting. Visitor and security and reading from written text, please applications, the disclosure of which information for those attending in- bring 20 copies of the statement for would constitute a clearly unwarranted person is available at niehs.nih.gov/ distribution to the BSC and NTP staff invasion of personal privacy. about/visiting/index.cfm. Individuals and to supplement the record. with disabilities who need Name of Committee: National Cancer Background Information on the BSC: Institute Special Emphasis Panel accommodation to participate in this The BSC is a technical advisory body Quantitative Imaging for Evaluation of event should contact Dr. White at comprised of scientists from the public Response to Cancer Therapies (U01). phone: (919) 541–9834 or email: and private sectors that provides Date: May 13, 2015. whiteld@niehs.nih.gov. TTY users Time: 10:30 a.m. to 5:00 p.m. primary scientific oversight to the NTP. should contact the Federal TTY Relay Agenda: To review and evaluate grant Specifically, the BSC advises the NTP applications. Service at 800–877–8339. Requests should be made at least five business on matters of scientific program content, Place: National Cancer Institute Shady days in advance of the event. both present and future, and conducts Grove, 9609 Medical Center Drive, Room Request for Comments: Written periodic review of the program for the 5W032, Rockville, MD 20850, (Telephone purpose of determining and advising on Conference Call). comments submitted in response to this Contact Person: Gerald G. Lovinger, Ph.D., notice should be received by June 2, the scientific merit of its activities and Scientific Review Officer, 9609 Medical 2015. Comments will be posted on the their overall scientific quality. Its Center Drive, Room 7W266, Research BSC meeting Web site and persons members are selected from recognized Technology and Contract Review Branch, submitting them will be identified by authorities knowledgeable in fields such Division of Extramural Activities, National their name and affiliation and/or as toxicology, pharmacology, pathology, Cancer Institute, NIH, Bethesda, MD 20892– sponsoring organization, if applicable. biochemistry, epidemiology, risk 9750, (240) 276–6385, lovingeg@mail.nih.gov. Persons submitting written comments assessment, carcinogenesis, This notice is being published less than 15 should include their name, affiliation (if days prior to the meeting due to the timing mutagenesis, molecular biology, applicable), phone, email, and limitations imposed by the review and behavioral toxicology, neurotoxicology, funding cycle. sponsoring organization (if any) with immunotoxicology, reproductive Name of Committee: National Cancer the document. toxicology or teratology, and Institute Special Emphasis Panel NCI Time is allotted during the meeting Omnibus R03 & R21 SEP–2. biostatistics. Members serve overlapping for the public to present oral comments Date: June 1–2, 2015. terms of up to four years. The BSC to the BSC on the agenda topics. Public Time: 8:00 a.m. to 2:00 p.m. usually meets biannually. The authority comments can be presented in-person at Agenda: To review and evaluate grant the meeting or by teleconference line. for the BSC is provided by 42 U.S.C. applications. There are 50 lines for this call; 217a, section 222 of the Public Health Place: Ritz-Carlton Hotel, 1700 Tysons asabaliauskas on DSK5VPTVN1PROD with NOTICES availability is on a first-come, first- Service Act (PHS), as amended. The Boulevard, McLean, VA 22102. BSC is governed by the provisions of the Contact Person: Eun Ah Cho, Ph.D., served basis. The lines will be open Federal Advisory Committee Act, as Scientific Review Officer, Special Review from 8:30 until adjournment, although Branch, Division of Extramural Activities, the BSC will receive public comments amended (5 U.S.C. app.), which sets National Cancer Institute, NIH, 9609 Medical only during the formal public comment forth standards for the formation and Center Drive, 7W104, Bethesda, MD 20892– periods, which are indicated on the use of advisory committees. 9750, 240–276–6342, choe@mail.nih.gov. preliminary agenda. Each organization (Catalogue of Federal Domestic Assistance is allowed one time slot per agenda Program Nos. 93.392, Cancer Construction; VerDate Sep<11>2014 18:18 Apr 27, 2015 Jkt 235001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\28APN1.SGM 28APN1

23562 Federal Register / Vol. 80, No. 81 / Tuesday, April 28, 2015 / Notices 93.393, Cancer Cause and Prevention Contact Person: William C. Benzing, Ph.D., Agenda: To review and evaluate grant Research; 93.394, Cancer Detection and Scientific Review Officer, Scientific Review applications. Diagnosis Research; 93.395, Cancer Branch, Division of Extramural Research, Place: National Institutes of Health, 5601 Treatment Research; 93.396, Cancer Biology NINDS/NIH/DHHS/Neuroscience Center, Fishers Lane, Rockville, MD 20852, Research; 93.397, Cancer Centers Support; 6001 Executive Boulevard, Suite 3208, MSC (Telephone Conference Call). 93.398, Cancer Research Manpower; 93.399, 9529, Bethesda, MD 20892–9529, 301–496– Contact Person: Susana Mendez, Ph.D., Cancer Control, National Institutes of Health, 0660, benzingw@mail.nih.gov. DVM, Scientific Review Officer, Scientific HHS) Name of Committee: National Institute of Review Program, DEA/NIAID/NIH/DHHS, Neurological Disorders and Stroke Special 5601 Fishers Lane, Room 3G53B, MSC 9823, Dated: April 22, 2015. Rockville, MD 20852, 240–669–5059, Emphasis Panel, NIH–NINDS BRAIN Melanie J. Gray, Initiative (005) Review. mendezs@niaid.nih.gov. Program Analyst, Office of Federal Advisory Date: June 22–23, 2015. (Catalogue of Federal Domestic Assistance Committee Policy. Time: 8:00 a.m. to 6:00 p.m. Program Nos. 93.855, Allergy, Immunology, [FR Doc. 2015–09777 Filed 4–27–15; 8:45 am] Agenda: To review and evaluate grant and Transplantation Research; 93.856, BILLING CODE 4140–01–P applications. Microbiology and Infectious Diseases Place: Bethesda North Marriott Hotel & Research, National Institutes of Health, HHS) Conference Center, 5701 Marinelli Road, Dated: April 22, 2015. DEPARTMENT OF HEALTH AND Bethesda, MD 20852. Contact Person: Raul A. Saavedra, Ph.D., David Clary, HUMAN SERVICES Program Analyst, Office of Federal Advisory Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, Committee Policy. National Institutes of Health NINDS/NIH/DHHS/Neuroscience Center, [FR Doc. 2015–09781 Filed 4–27–15; 8:45 am] National Institute of Neurological 6001 Executive Boulevard, Suite 3208, MSC BILLING CODE 4140–01–P 9529, Bethesda, MD 20892–9529, 301–496– Disorders and Stroke; Notice of Closed 9223, saavedrr@ninds.nih.gov Meetings (Catalogue of Federal Domestic Assistance DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the Program Nos. 93.853, Clinical Research HUMAN SERVICES Federal Advisory Committee Act, as Related to Neurological Disorders; 93.854, amended (5 U.S.C. App.), notice is Biological Basis Research in the National Institutes of Health Neurosciences, National Institutes of Health, hereby given of the following meetings. HHS) National Center for Complementary & The meetings will be closed to the public in accordance with the Dated: April 22, 2015. Integrative Health; Notice of Meeting provisions set forth in sections Carolyn Baum, Pursuant to section 10(d) of the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Federal Advisory Committee Act, as Program Analyst, Office of Federal Advisory as amended. The grant applications and Committee Policy. amended (5 U.S.C. App.), notice is the discussions could disclose hereby given of a meeting of the [FR Doc. 2015–09778 Filed 4–27–15; 8:45 am] confidential trade secrets or commercial National Advisory Council for BILLING CODE 4140–01–P property such as patentable material, Complementary and Integrative Health. and personal information concerning The meeting will be open to the individuals associated with the grant DEPARTMENT OF HEALTH AND public as indicated below, with applications, the disclosure of which HUMAN SERVICES attendance limited to space available. would constitute a clearly unwarranted Individuals who plan to attend and invasion of personal privacy. National Institutes of Health need special assistance, such as sign Name of Committee: National Institute of language interpretation or other Neurological Disorders and Stroke Special National Institute of Allergy and reasonable accommodations, should Emphasis Panel, Chronic Traumatic Infectious Diseases; Notice of Closed notify the Contact Person listed below Encephalopathy SEP. Meeting in advance of the meeting. Date: April 30, 2015. The meeting will be closed to the Time: 1:00 p.m. to 5:00 p.m. Pursuant to section 10(d) of the Agenda: To review and evaluate Federal Advisory Committee Act, as public in accordance with the cooperative agreement applications. amended (5 U.S.C. App.), notice is provisions set forth in sections Place: National Institutes of Health, hereby given of the following meeting. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Neuroscience Center, 6001 Executive The meeting will be closed to the as amended. The grant applications and Boulevard, Rockville, MD 20852, (Telephone public in accordance with the the discussions could disclose Conference Call). confidential trade secrets or commercial Contact Person: Shanta Rajaram, Ph.D., provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., property such as patentable material, Scientific Review Officer, Scientific Review and personal information concerning Branch, Division of Extramural Research, as amended. The grant applications and NINDS/NIH/DHHS/Neuroscience Center, the discussions could disclose individuals associated with the grant 6001 Executive Boulevard, Suite 3208, MSC confidential trade secrets or commercial applications, the disclosure of which 9529, Bethesda, MD 20892–9529, 301–435– property such as patentable material, would constitute a clearly unwarranted 6033, rajarams@mail.nih.gov. and personal information concerning invasion of personal privacy. Name of Committee: National Institute of individuals associated with the grant Name of Committee: National Advisory Neurological Disorders and Stroke Special Council for Complementary and Integrative asabaliauskas on DSK5VPTVN1PROD with NOTICES applications, the disclosure of which Emphasis Panel, NINDS P01 REVIEWS. Health. would constitute a clearly unwarranted Date: May 4, 2015. Date: June 5, 2015. Time: 1:00 p.m. to 5:00 p.m. invasion of personal privacy. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant Name of Committee: National Institute of Agenda: To review and evaluate grant applications. Allergy and Infectious Diseases Special applications. Place: National Institutes of Health, Emphasis Panel NIAID Investigator Initiated Place: National Institutes of Health, Neuroscience Center, 6001 Executive Program Project Applications (P01). Building 31, Conference Room 10, 31 Center Boulevard, Rockville, MD 20852, (Telephone Date: May 20, 2015. Drive, Bethesda, MD 20892. Conference Call). Time: 11:00 a.m. to 3:00 p.m. Open: 10:30 a.m. to 4:00 p.m. VerDate Sep<11>2014 18:18 Apr 27, 2015 Jkt 235001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\28APN1.SGM 28APN1


Document Created: 2015-12-16 08:36:13
Document Modified: 2015-12-16 08:36:13
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMay 13, 2015.
FR Citation80 FR 23561 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR